$JAZZ Company News 13 stocks set to outperform i
Post# of 102919
Posted On: 01/25/2014 11:25:46 AM
$JAZZ Company News
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 11:15 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Meda buys women's-health portfolio in US for $95M 1:56 a.m. Sept. 6, 2012 - MarketWatch.com
The bull market is starting to stray 12:02 a.m. Feb. 16, 2012 - The Trading Deck
Nasdaq sustains break to 11-year highs 11:31 a.m. Feb. 7, 2012 - Michael Ashbaugh
Nasdaq sustains break to 11-year highs 11:00 a.m. Feb. 7, 2012 - Michael Ashbaugh
January uptrend meets major resistance 11:15 a.m. Jan. 24, 2012 - Michael Ashbaugh
U.S. benchmarks hesitate at major resistance 10:49 a.m. Jan. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 24, 2014 - Zacks.com
Tech, Health Care Lead Early Strength In Weekly Review 4:48 p.m. Jan. 23, 2014 - Investors Business Daily
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog 1:01 p.m. Jan. 22, 2014 - Zacks.com
Why Investors Are Shrugging Off Amag Pharma's Feraheme FDA Rejection 11:54 a.m. Jan. 22, 2014 - TheStreet.com
Illumina, Jazz Among 5 Young Guns Hitting New Highs 7:02 a.m. Jan. 22, 2014 - Investors Business Daily
Going Solar 12:00 p.m. Jan. 18, 2014 - RealMoney.com
Several IBD 50 Medical Companies Seen Posting Strong Q4 Profit Gains 5:16 p.m. Jan. 17, 2014 - Investors Business Daily
New Lifetime High For Jazz Pharmaceuticals (JAZZ) 9:45 a.m. Jan. 17, 2014 - TheStreet.com
Stick with the Positive Trend 7:41 a.m. Jan. 17, 2014 - RealMoney.com
The Action Is High 4:34 p.m. Jan. 15, 2014 - RealMoney.com
Building a 'Wall of Worry' 2:01 p.m. Jan. 15, 2014 - RealMoney.com
Odds Favor Further Upside 10:37 a.m. Jan. 15, 2014 - RealMoney.com
BioCryst Pharmaceuticals (BCRX) Soars: Stock Up 8.6% - Tale of the Tape 8:51 a.m. Jan. 15, 2014 - Zacks.com
Cantor Fitzgerald Shows Best Global Equity Research Ideas for 2014 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
Dendreon Up on Prelim Q4 Results - Analyst Blog 5:23 p.m. Jan. 14, 2014 - Zacks.com
AMAG's Feraheme Revs Look Good - Analyst Blog 5:20 p.m. Jan. 14, 2014 - Zacks.com
Jazz Pharma Acquires Sleep Drug - Analyst Blog 5:10 p.m. Jan. 14, 2014 - Zacks.com
Avanir Gives Preliminary Q1 Update - Analyst Blog 4:55 p.m. Jan. 14, 2014 - Zacks.com
Jazz Pharma acquires narcolepsy drug 3:51 p.m. Jan. 14, 2014 - Seeking Alpha
The Bulls Are Optimistic 1:13 p.m. Jan. 14, 2014 - RealMoney.com
Jazz Pharmaceuticals plc Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares 2:24 a.m. Jan. 23, 2014 - PR Newswire - PRF
Critical Alerts For Vodafone, PetSmart, Gamestop, Constellation brands, and Jazz Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Jan. 22, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness 8:05 a.m. Jan. 13, 2014 - PR Newswire - PRF
Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 8:00 a.m. Jan. 9, 2014 - PR Newswire
Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13 4:15 p.m. Jan. 6, 2014 - PR Newswire
Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio 8:00 a.m. Dec. 25, 2013 - PR Newswire
InVivo Names Mark Perrin as Its New Chief Executive Officer 4:30 p.m. Dec. 23, 2013 - BusinessWire
Gentium S.p.A. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Jazz Pharmaceuticals 11:12 a.m. Dec. 20, 2013 - BusinessWire
Jazz Pharmaceuticals and Gentium S.p.A. Announce Agreement for Jazz Pharmaceuticals to Acquire Gentium for $57.00 Per Share 4:48 p.m. Dec. 19, 2013 - GlobeNewswire
Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share 4:43 p.m. Dec. 19, 2013 - PR Newswire
Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals 8:00 a.m. Dec. 19, 2013 - PR Newswire
Quarterly Changes to the NASDAQ OMX Q-50 Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Corporate Directors From ON Semiconductor, Carpenter Technology and AARP Become NACD Fellows 9:01 a.m. Dec. 3, 2013 - GlobeNewswire
Upcoming Investor Conference Presentations, Donations and Acquisitions - Research Report on Jazz Pharmaceuticals, DENTSPLY, Teleflex, DexCom, and Cell Therapeutics 8:00 a.m. Nov. 28, 2013 - PR Newswire
Jazz Pharmaceuticals Announces Participation at the Piper Jaffray Healthcare Conference on December 3 4:05 p.m. Nov. 20, 2013 - PR Newswire
Stock Price Movements, Share Repurchase Programs, and Financial Results - Research Report on Jazz Pharmaceuticals, Novo Nordisk, Teleflex, DENTSPLY International, and Fonar 8:00 a.m. Nov. 20, 2013 - PR Newswire
Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences 8:00 a.m. Nov. 6, 2013 - PR Newswire
Jazz Pharmaceuticals Announces Third Quarter 2013 Financial Results 4:05 p.m. Nov. 5, 2013 - PR Newswire
Commencement of Clinical Trials, Financial Results, Upcoming Earnings Releases, and Asset Acquisitions - Research Report on Questcor, Jazz Pharmaceuticals, Ariad, and USANA 7:00 a.m. Oct. 25, 2013 - PR Newswire
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 11:15 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Meda buys women's-health portfolio in US for $95M 1:56 a.m. Sept. 6, 2012 - MarketWatch.com
The bull market is starting to stray 12:02 a.m. Feb. 16, 2012 - The Trading Deck
Nasdaq sustains break to 11-year highs 11:31 a.m. Feb. 7, 2012 - Michael Ashbaugh
Nasdaq sustains break to 11-year highs 11:00 a.m. Feb. 7, 2012 - Michael Ashbaugh
January uptrend meets major resistance 11:15 a.m. Jan. 24, 2012 - Michael Ashbaugh
U.S. benchmarks hesitate at major resistance 10:49 a.m. Jan. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 24, 2014 - Zacks.com
Tech, Health Care Lead Early Strength In Weekly Review 4:48 p.m. Jan. 23, 2014 - Investors Business Daily
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog 1:01 p.m. Jan. 22, 2014 - Zacks.com
Why Investors Are Shrugging Off Amag Pharma's Feraheme FDA Rejection 11:54 a.m. Jan. 22, 2014 - TheStreet.com
Illumina, Jazz Among 5 Young Guns Hitting New Highs 7:02 a.m. Jan. 22, 2014 - Investors Business Daily
Going Solar 12:00 p.m. Jan. 18, 2014 - RealMoney.com
Several IBD 50 Medical Companies Seen Posting Strong Q4 Profit Gains 5:16 p.m. Jan. 17, 2014 - Investors Business Daily
New Lifetime High For Jazz Pharmaceuticals (JAZZ) 9:45 a.m. Jan. 17, 2014 - TheStreet.com
Stick with the Positive Trend 7:41 a.m. Jan. 17, 2014 - RealMoney.com
The Action Is High 4:34 p.m. Jan. 15, 2014 - RealMoney.com
Building a 'Wall of Worry' 2:01 p.m. Jan. 15, 2014 - RealMoney.com
Odds Favor Further Upside 10:37 a.m. Jan. 15, 2014 - RealMoney.com
BioCryst Pharmaceuticals (BCRX) Soars: Stock Up 8.6% - Tale of the Tape 8:51 a.m. Jan. 15, 2014 - Zacks.com
Cantor Fitzgerald Shows Best Global Equity Research Ideas for 2014 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
Dendreon Up on Prelim Q4 Results - Analyst Blog 5:23 p.m. Jan. 14, 2014 - Zacks.com
AMAG's Feraheme Revs Look Good - Analyst Blog 5:20 p.m. Jan. 14, 2014 - Zacks.com
Jazz Pharma Acquires Sleep Drug - Analyst Blog 5:10 p.m. Jan. 14, 2014 - Zacks.com
Avanir Gives Preliminary Q1 Update - Analyst Blog 4:55 p.m. Jan. 14, 2014 - Zacks.com
Jazz Pharma acquires narcolepsy drug 3:51 p.m. Jan. 14, 2014 - Seeking Alpha
The Bulls Are Optimistic 1:13 p.m. Jan. 14, 2014 - RealMoney.com
Jazz Pharmaceuticals plc Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares 2:24 a.m. Jan. 23, 2014 - PR Newswire - PRF
Critical Alerts For Vodafone, PetSmart, Gamestop, Constellation brands, and Jazz Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Jan. 22, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness 8:05 a.m. Jan. 13, 2014 - PR Newswire - PRF
Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 8:00 a.m. Jan. 9, 2014 - PR Newswire
Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13 4:15 p.m. Jan. 6, 2014 - PR Newswire
Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio 8:00 a.m. Dec. 25, 2013 - PR Newswire
InVivo Names Mark Perrin as Its New Chief Executive Officer 4:30 p.m. Dec. 23, 2013 - BusinessWire
Gentium S.p.A. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Jazz Pharmaceuticals 11:12 a.m. Dec. 20, 2013 - BusinessWire
Jazz Pharmaceuticals and Gentium S.p.A. Announce Agreement for Jazz Pharmaceuticals to Acquire Gentium for $57.00 Per Share 4:48 p.m. Dec. 19, 2013 - GlobeNewswire
Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share 4:43 p.m. Dec. 19, 2013 - PR Newswire
Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals 8:00 a.m. Dec. 19, 2013 - PR Newswire
Quarterly Changes to the NASDAQ OMX Q-50 Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Corporate Directors From ON Semiconductor, Carpenter Technology and AARP Become NACD Fellows 9:01 a.m. Dec. 3, 2013 - GlobeNewswire
Upcoming Investor Conference Presentations, Donations and Acquisitions - Research Report on Jazz Pharmaceuticals, DENTSPLY, Teleflex, DexCom, and Cell Therapeutics 8:00 a.m. Nov. 28, 2013 - PR Newswire
Jazz Pharmaceuticals Announces Participation at the Piper Jaffray Healthcare Conference on December 3 4:05 p.m. Nov. 20, 2013 - PR Newswire
Stock Price Movements, Share Repurchase Programs, and Financial Results - Research Report on Jazz Pharmaceuticals, Novo Nordisk, Teleflex, DENTSPLY International, and Fonar 8:00 a.m. Nov. 20, 2013 - PR Newswire
Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences 8:00 a.m. Nov. 6, 2013 - PR Newswire
Jazz Pharmaceuticals Announces Third Quarter 2013 Financial Results 4:05 p.m. Nov. 5, 2013 - PR Newswire
Commencement of Clinical Trials, Financial Results, Upcoming Earnings Releases, and Asset Acquisitions - Research Report on Questcor, Jazz Pharmaceuticals, Ariad, and USANA 7:00 a.m. Oct. 25, 2013 - PR Newswire
(0)
(0)